NEVVI Medicare utilization intelligence

← back

GUNUGANTI, VIJAYM.D. NPI 1073535076 Clinician

Medical Oncology · SAN ANTONIO, TX

Specialty Medical Oncology — from billed Medicare claims
In practice about 31 years since medical school (class of 1995, self-reported to CMS)
Location SAN ANTONIO, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 69 codes billed · 99,031 disclosed volume (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
GREATER TEXAS PALLIATIVE CARE SERVICES PLLC
2020–2026
TEXAS ONCOLOGY PA
2019–2026
5 STAR INTEGRITY HEALTHCARE, LLC
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2016-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9299 Injection, nivolumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9267 Injection, paclitaxel, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1626 Injection, granisetron hydrochloride, 100 mcg
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
J9190 Injection, fluorouracil, 500 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J9045 Injection, carboplatin, 50 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
82784 Gammaglobulin (immune system protein) measurement
82378 Carcinoembryonic antigen (cea) protein level
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
96375 Injection of additional new drug or substance into vein
96372 Injection of drug or substance under skin or into muscle
84153 Psa (prostate specific antigen) measurement, total
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
83615 Lactate dehydrogenase (enzyme) level
83521 Measurement of immunoglobulin light chains
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J3489 Injection, zoledronic acid, 1 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
J3490 Unclassified drugs
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
85055 Reticulated (young) platelet measurement
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96523 Irrigation of implanted venous access drug delivery device
96411 Administration of additional new drug or substance into vein using push technique
J7030 Infusion, normal saline solution , 1000 cc
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
80048 Blood test, basic group of blood chemicals (calcium, total)
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
71260 Ct scan of chest with contrast
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
96361 Infusion into a vein for hydration, each additional hour
74177 Ct scan of abdomen and pelvis with contrast
84443 Blood test, thyroid stimulating hormone (tsh)
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99195 Drawing of blood for a medical problem
88184 Flow cytometry technique for dna or cell analysis, first marker
96360 Infusion into a vein for hydration, 31-60 minutes
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.